Company / Operating Income
Entera Bio Ltd. Operating Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$9.6M
FY2025
5-year range
-$13.0M / -$8.9M
FY2021-FY2025
Trend
-7.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$13M to -$10M over the past 2 years.
Based on SEC 10-K filings.
-$10M in FY2025.
Improved from -$13M to -$10M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 7.8% year-over-year.
- Peak operating income was recorded in FY2024.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$9.6M | -7.8% |
| FY2024 | -$8.9M | +31.7% |
| FY2023 | -$13.0M | -6.5% |
| FY2022 | -$12.2M | -9.4% |
| FY2021 | -$11.2M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026